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A B ST R AC T  
 
Aim: To investigate the clinical effect of the computer-aided sperm analyzers (CASA) by comparing 
the low sperm concentration semen samples evaluated by CASA with the sperm count performed on 
Makler Counting Chamber (MC) as a manual method. 
Methods: Semen samples were taken from184 patients coming to our clinic were evaluated with 
CASA (SQA-V Gold sperm analyzer, MES Medical Electronic Systems Ltd. Caesarea Industrial 
Park, IL 3088900, UK) and MC (Makler Counting Chamber, Sefi-Medical Instruments ltd., Haifa, 
Israel). Samples were divided into two groups as samples containing sperms and samples without 
sperms, according to the CASA results. 
Results: There was a very high correlation between the two measurement methods (rho = 0.982) and 
regression analysis formula was y=1.042x-0.104. No sperm was detected in CASA in any of the 
samples identified to have no sperm in MC. However, when patients who were identified with no 
sperm in their CASA measurements (n=51) were analyzed with MC, 29 patient samples (56.9%) had 
an average of 0.23±0.35 x106 /mL sperm. 
Conclusion: CASA’s used in routine semen analysis provide a great convenience in measuring sperm 
count, compared to manual methods and provide highly correlated results. Manual verification of 
samples can be recommended since the samples diagnosed with azoospermia provided different 
results with a manual method in our study. 
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Introduction 
Infertility is a potentially life-changing 
diagnosis for couples who are trying to 
conceive. It can be defined as the condition of 
not being able to conceive despite regular 
unprotected intercourse for at least 12 
consecutive months [1,2]. Male factor is 
suspected in approximately half of the cases [3]. 
The most common and precise diagnostic step 
in male infertility is semen analysis. Semen 
analysis helps to investigate male infertility and 
provides basic data on the contribution of the 
male factor for an infertile couple [4]. It also 
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helps to identify reversible medical conditions 
that can affect fertility [5]. The subjectivity of 
the evaluation and interpersonal variation of 
sperm concentration and motility are the most 
significant limitations of this technique [6]. The 
diagnostic and prognostic effectiveness of 
semen analysis is correlated with strict 
compliance to the guidelines recommended by 
the World Health Organization. Neubauer slide 
(NS), Makler counting chamber (MC), 
spectrophotometric methods and fully 
automated (or computer-aided) sperm 
analyzers (CASA) can be used for sperm 
counting [3,6,7]. Spermatozoa motility, 
morphology and concentration can be analyzed 
simultaneously on modern CASA systems but 
such assessments are not as reliable as 
traditional methods (such as NS or MC) [8,9]. 
Computerized systems such as CASA, are more 
convenient for analyzing complex parameters 
such as sperm motility and offer an objective 
and fast method for semen analysis. CASA uses 
a microscope, camera and computer software 
for sperm motility analysis [7,8]. In traditional 
semen analysis methods, sperm cells in the 
semen placed on a slide such as NS or MC are 
counted on the microscope [10]. The complete 
absence of sperm in semen analysis is defined 
as azoospermia [6,11]. Azoospermia is the 
definition of the semen rather than the basis of 
diagnosis and treatment or the cause of sperm 
absence [10]. However, azoospermia is not the 
case even if there is a single sperm in the semen. 
Even the case of a single sperm can affect the 
treatment and this becomes a condition of 
subfertility rather than infertility [12]. Although 
seemingly simple, the diagnosis of azoospermia 
is complicated by many factors, such as 
significant errors associated with counting a 
small number of spermatozoa, a large number 
of microscopic fields to be examined, and the 
difficulty of examining debris-loaded sperm 
pellets. It is recommended to examine fixed but 
non-centrifuged samples to overcome these 
situations [10].  
In the widely used CASA, patients with a very 
low amount of sperm in their semen who are 
diagnosed with azoospermia is a frequent 
situation. This study investigates the clinical 
effect of CASA by comparing the low sperm 
concentration semen samples evaluated by 
CASA with the sperm count performed on MC.  
 
Materials and Methods 
The study was approved by Bolu Abant Izzet 
Baysal University, Clinical Research Ethics 
Committee, decision number 2020/60, dated 
07/04/2020. Semen samples were taken 
from184 patients, who applied and gave written 
consent to the male infertility laboratory. The 
samples were macroscopically confirmed to be 
semen samples. Semen samples were obtained 
through masturbation by dry method in sterile 
containers. Samples were analyzed after 
liquefaction in the incubator (Heraeus, Thermo 
Electron Corporation, Langenselbold, 
Germany) for about 30 minutes at 37°C and 
thorough mixing. Samples which were less than 
1 ml and more than 4 ml, samples that were not 
treated with liquefaction within 30 minutes and 
samples showing hyperviscosity were excluded 
from the study [10,13-15]. Fresh semen 
samples were evaluated without dilution and 
processing on the samples included in the study. 
All procedures performed in this study were in 
accordance with the ethical standards of the 
institutional and/or national research committee 
and with the 1964 Helsinki declaration and its 
later ammendense or comparable ethical 
standards. 
Semen samples were analyzed with SQA-V 
Gold sperm analyzer (SQA-V Gold sperm 
analyzer, MES Medical Electronic Systems 
Ltd. Caesarea Industrial Park, IL 3088900, UK) 
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for CASA method, and MC (Makler Counting 
Chamber, Sefi-Medical Instruments ltd., Haifa, 
Israel) for manual method. Samples were taken 
blindly from the same pool to be evaluated 
blindly at the same time and transferred to the 
device for CASA and to the microscope with 
MC for manual method. In sperm analysis, the 
sperm concentration was determined as 
106/mL. Motility in sperm analysis was 
evaluated as; progressively motile, non-
progressively motile and immotile. Motility 
rates were given as a percentage of total sperm 
count. Samples were divided into two groups as 
samples containing sperms and samples 
without sperms, according to the CASA results. 
The manual microscopic method was 
performed in compliance with the standard 
protocol in the WHO 2010 guideline [6,10].  
Automated analysis was performed by using 
the laboratory-based CASA system, SQA-V 
Gold sperm analyzer. Automatic semen 
analysis was performed in accordance with the 
protocol of the manufacturing company. In 
summary, samples were mixed thoroughly and 
inserted in the device's electro-optic chamber 
with a capillary for CASA counting. Sperm 
counts and movements are reported 















through special algorithms in the computer 
system by translating the light-beams into 
electrical signals. The measurement range for 
the sperm concentration of the SQA-V Gold 
sperm analyzer was specified as 0-700 106/mL 
by the manufacturer. 
Statistical analysis 
Statistical analysis of the data was performed 
through the SPSS program (version 17.0, SPSS 
Inc., Chicago, IL, USA). The conformity of the 
numerical values to normal distribution was 
evaluated through the Kolmogorov-Smirnov 
test. Descriptive data were presented as mean ± 
standard deviation and median (1st - 3rd quarter). 
Wilcoxon-rank test was used in the comparison 
of dependent variables after it was determined 
that the data did not conform to normal 
distribution. McNemar test was used in the 
comparison of paired nominal data. Passing-
Bablok regression analysis and Spearman 
correlation analysis were used to evaluate the 
compatibility between the two methods. p<0.05 
was considered to be statistically significant. 
 
Results  
CASA and MC semen analysis results are 
shown in Table 1. The median sperm count 



















x̄±SD Md (Q1-Q3) x̄±SD Md (Q1-Q3) 
Sperm number (x106/mL) 
 29±33.9 16.4 (0-46.8) 28±31.8 16 (0.2-40) 0.066 
Immotile (%) 
37.5±33.3 35 (0-68.8) 51.3±31.7 50 (25.3-79) <0.001 
Non-progressive motile (%) 
10.7±10.9 10 (0-17) 19.2±17.1 20 (0.8-30) <0.001 
Progressively motile (%) 
24.4±26.6 15 (0-44.8) 16.1±20.2 10 (0-30) <0.001 
x̄±SD: mean ± Standart deviation, Md (Q1-Q3): Median (1st-3rd quartile),*: Wilcoxon signed-rank test. CASA: 
computer-aided sperm analyzers. MC: Makler Counting Chamber. 
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(0.0 - 46.8) and 16.0 (0.2 - 40.0), respectively, 
and there was no statistical difference between 
the two values (p = 0.066). There was a very 
high correlation between the two measurement 
methods (rho = 0.982) and the Passing-Bablok 
regression analysis formula was y = 1.042x-
0.104 (Figure 1). Comparison of groups with 
and without sperm according to CASA and MC 
is shown in Table 2. No sperm was detected in 
CASA in any of the samples identified to have 
no sperm in MC. However, when patients who 
were identified with no sperm in their CASA 
measurements (n = 51) were analyzed with MC, 
29 patient samples (56.9%) had an average 





























In our study where sperm concentrations in 
semen analysis were evaluated, the semen 
samples that arrived at our laboratory were 
examined with CASA and MC and being the 
diagnostic criteria in the diagnosis of 
azoospermia, only sperm concentrations were 
compared. In the measurements performed by 
CASA and MC, there was a high correlation 
with regards to sperm concentration. In 57% of 
the samples that would be diagnosed as 
azoospermia through CASA, the presence of 
sperm was detected through MC. 
In studies have shown high correlations 
between CASA and manual methods with 

















found a correlation of 0.84 between methods in 
terms of sperm concentration [16]. Similarly, 
Lammers et al. showed that there was a 0.95 
correlation between various CASA methods 
and manual method in terms of sperm count 
[17]. In parallel to the literature, a correlation of 
0.98 was found between CASA and the manual 
method in our study.  
Wang et al. [7] stated that sperm motility and 
morphology were associated with the time until 
Figure 1. Passing-Bablok regression (A) and Blant-Altman (B) plots of CASA and MC sperm numbers. 
 
Table 2. Comparison of the groups with and without 
sperm according to CASA and MC. 
Parameters  
No-sperm 
in MC  
Sperm in 
MC 














*McNemar’s test. CASA: computer-aided sperm 
analyzers. MC: Makler Counting Chamber. 
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natural pregnancy, while sperm motility might 
be less predictive. Gnoth et al. [12] named the 
absence of sperm as azoospermia and classified 
the prolonged time to conceive as subfertility. 
In our study, sperm count was evaluated and it 
was observed that when the same samples were 
examined with two different methods with 
regards to azoospermia, sperms could be found 
in the samples that were reported as 
azoospermia with CASA when analyzed in 
detail with the manual method.  
Bjorndahl et al. [18] prepared a guideline to 
journals for better sperm analysis evaluations. 
They developed criteria for evaluation of the 
general analysis, concentration, motility, 
morphology, sperm viability, other findings and 
analysis data in the evaluation of semen 
analysis. Our study fulfilled all seven criteria of 
sperm concentration evaluation in this guide. 
As a result of the improvements in CASA 
systems in parallel with the development of 
hardware, the capability to gradually analyze 
the concentration of moving spermatozoa by 
using fluorescent DNA stain and a tail detection 
algorithm in addition to sperm concentration 
provided a superiority over manual methods in 
motility measurement [9,19]. However, in our 
study, different clinical findings were shown in 
semen analysis in very low concentrations 
which could not be measured by CASA. 
Detecting sperms in 57% of the samples that 
cannot be measured by CASA through manual 
evaluation demonstrates the importance of 
verification of sperm analysis in very low 
concentrations with a manual method, despite 
the current improvements and superiority of 
CASA over manual methods in certain 
parameters.  
Although it is known that sperm parameters can 
be extremely variable even if the sperm analysis 
results of the same individuals do not differ 
significantly at various times, it is stated that 
sperm concentration analysis is one of the most 
reliable methods [20]. Variability is even more 
important at low sperm concentrations, and our 
study recommends the analysis of these low-
concentration samples with more than one 
method. 
Currently, in clinical laboratories worldwide, a 
semen analysis is still based on a manual 
microscopy method. However, some of the 
major disadvantages of this technique are that it 
is labour-intensive, subjective, laboratory-
based, and time-consuming. Although partial 
automation of routine semen analysis with 
CASA is adopted in clinical use, it is reported 
in studies that it is still in the development 
phase to receive wider acceptance 
[15,19,21,22]. Our study on the other hand, 
emphasizes that a manual microscopy method 
is required clinically, specifically in 
approaching the azoospermia cases.  
Conclusions 
CASA’s used in routine semen analysis provide 
a great convenience in measuring sperm count, 
compared to manual methods and provide 
highly correlated results. However, in the 
evaluation of azoospermia, it is known that the 
presence of even a single sperm in the sample 
may change the clinic and treatment. Manual 
verification of samples can be recommended 
since the samples diagnosed with azoospermia 
provided different results with a manual 
method in our study. 
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